Ligation of the CD28 surface receptor provides a major costimulatory signal
for full scale T cell activation. Despite extensive studies, the intracell
ular signaling pathways delivered by CD28 ligation are not fully understood
. A particularly controversial matter is the role of phosphatidylinositol 3
-kinase (PI3K) in CD28-mediated costimulation. It is known that the binding
site for PI3K and Grb-2 lies nested within the YMNM motif of the CD28 cyto
plasmic domain. To elucidate the role of PI3K during CD28-mediated interleu
kin-2 (IL-2) production, CD28 YMNM point and deletion mutants were expresse
d in Jurkat cells. We then measured IL-2 promoter activation after CD28 lig
ation. Our results showed that the Y189F mutant, which disrupts binding by
PI3K, and the YMNM deletion mutant both demonstrated reduced but significan
t activity for IL-2 promoter activation. In contrast, the N191A mutant, whi
ch retains PI3K binding ability, resulted in a complete abrogation of activ
ity, suggesting that PI3K mediates a negative effect upon transcriptional a
ctivation of the IL-2 gene. Consistent with this idea, we found that the ad
dition of a PI3K pharmacological inhibitor augmented IL-2 promoter activity
, whereas coexpression of a constitutively active form of PI3K reduced this
activity. Taken together, these data indicate that PI3K, when associated w
ith the YMNM motif, may act as a negative mediator in CD28-mediated IL-2 ge
ne transcription.